The management of epithelial ovarian cancer: neoadjuvant chemotherapy and interval surgery

Authors

  • David G Allen University of Melbourne

Keywords:

Ovarian cancer, Neoadjuvant chemotherapy, interval surgery

Abstract

Ovarian cancer is the fourth most common cause of death from cancer in women and remains a significant problem. Treatment continues to be difficult as most women have advanced stage cancers at presentation. Some progress in terms of management and survival has been made in the last 20 years, but the mortality rate remains high. Improving outcomes in terms of mortality and quality of life will rely on a better understanding of the aetiology, effective population screening and increased management options.

Author Biography

  • David G Allen, University of Melbourne
    MBChB, MMed(O&G), FCOG(SA), FRANZCOG, CGO, PhD Mercy Hospital for Women Melbourne Australia

Downloads

Issue

Vol. 2 No. 2 (2010)

Section

Commentary

License

South African Journal of Gynaecological Oncology (SAJGO) Copyright is held by South African Society of Gynaecologic Oncology (SASGO). Copyright of the articles is held by the authors. The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License (CC BY NC). Material submitted for publication in the SAJGO is accepted provided it has not been published elsewhere. The SAJGO does not hold itself responsible for statements made by the authors. The opinions expressed in this publication are those of the authors. They do no purport to reflect the opinions or views of SASGO or its members.